フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
Strong Financial Performance Enables Procaps Group to Launch Private Placement of Senior Notes to Refinance Existing Debt with New Institutional...
Extraordinary General Meeting of Union Acquisition Corp. II (“LATN”) Shareholders to Approve the Proposed Business Combination with Procaps Group...
Procaps Group, a leading integrated international healthcare and pharmaceutical company, announced that in conjunction with Procaps Group’s...
Filed by Procaps Group pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the...
Senior Financial Executive (Previously CFO of CFR Pharmaceuticals) Brings 25 Years of Financial and Operational Experience to Lead Procaps Global...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
Filed by Procaps Group pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule...
Second Quarter 2021 Net Revenues Increased 35% to $97 Million Year-Over-Year with Adjusted EBITDA Up 28% Year-Over-Year Company Reaffirms...
Procaps to Introduce Senior Leadership Team, Review Reported Second Quarter 2021 Financial Results and Full Year 2021 Guidance with Analysts and...
Second Quarter 2021 Net Revenues Expected to Increase Over 25% Year-Over-Year, Resulting in First Half of 2021 Increasing Over 30...
Filed by Union Acquisition Corp. II pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule...
Company Reaffirms Full Year 2021 Net Revenue Guidance of $397 Million and Adjusted EBITDA Guidance of $105 Million Business Combination Remains...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す